STAR RK
Alternative Names: STAR-RKLatest Information Update: 28 Sep 2024
Price :
$50 *
At a glance
- Originator Starton Therapeutics
- Class Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Neurological disorders
Most Recent Events
- 28 Sep 2024 No recent reports of development identified for preclinical development in Neurological-disorders in USA (Transdermal)
- 26 Aug 2020 Preclinical trials in Neurological disorders in USA (Transdermal), before August 2020 (Starton Therapeutics pipeline, August 2020)